Metraipolis › archive › dc_c7107987d295
ATAD2 drives immunotherapy resistance by promoting lactic acid-mediated CD8+ T cell dysfunction in lung adenocarcinoma — Europe PMC PMID:41939918
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41939918
- DOI
- 10.3389/fimmu.2026.1800533
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T05:22:42.328Z
- SHA-256 of the archived text
439cad9f77d6a4db720cefae8683dd3888c600b69fd30698942929a55fa051c6- Stable URL of this page
https://metraipolis.com/documento/dc_c7107987d295
How to cite
ATAD2 drives immunotherapy resistance by promoting lactic acid-mediated CD8+ T cell dysfunction in lung adenocarcinoma — Europe PMC PMID:41939918 — Europe PMC (en), https://europepmc.org/article/MED/41939918 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c7107987d295 (Metraipolis archive dc_c7107987d295, sha256 439cad9f77d6a4db720cefae8683dd3888c600b69fd30698942929a55fa051c6)
BibTeX
@misc{dcc7107987d295,
title = {ATAD2 drives immunotherapy resistance by promoting lactic acid-mediated CD8+ T cell dysfunction in lung adenocarcinoma — Europe PMC PMID:41939918},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41939918},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c7107987d295; sha256 439cad9f77d6a4db720cefae8683dd3888c600b69fd30698942929a55fa051c6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41939918. Agents can read the archived copy with the MCP tool read_document.